AN2 THERAPEUTICS INC (ANTX) Institutional Buying Activity

Institutional investors tracked by InsiderSet increased exposure to AN2 THERAPEUTICS INC (ANTX) during the quarter ended March 31, 2026 through a combination of new purchases and expanded existing positions disclosed in SEC Form 13F filings.

The largest institutional buyer of ANTX during the latest reporting period was Renaissance Technologies LLC, which increased its reported ANTX position by approximately $438,165 based on quarter-end filing values. Several additional hedge funds and long-term asset managers also reported meaningful increases in ANTX exposure during the quarter.

Institutional buying activity can provide insight into investor conviction, sector allocation trends, and smart money positioning toward AN2 THERAPEUTICS INC (ANTX). InsiderSet tracks quarterly accumulation trends, new institutional positions, ownership increases, and estimated performance of newly disclosed holdings using SEC filing data and recent market prices.

The investors highlighted on this page collectively added approximately $685,561.552 in reported ANTX exposure during the latest filing period, reflecting continued institutional interest in AN2 THERAPEUTICS INC's growth initiatives and strategic positioning.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q2 2025Renaissance Technologies LLCBuy30,146398,854$422,785
Q4 2024Renaissance Technologies LLCBuy155,973579,773$800,087
Q3 2024Renaissance Technologies LLCBuy409,500423,800$453,466
Q2 2022Renaissance Technologies LLCBuy25,70025,700$199

Frequently asked questions about ANTX activity

  • Which institutional owners are buying ANTX?

    Institutional owners buying ANTX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ANTX activity?

    "Buy" means an investor increased their reported position in ANTX compared to the prior reporting period. This reflects growing exposure to AN2 THERAPEUTICS INC (ANTX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ANTX increasing?

    Institutional interest in ANTX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.